Literature DB >> 21817094

Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.

Ryo Saito1, Takashi Matsuzaka, Tadayoshi Karasawa, Motohiro Sekiya, Nazuki Okada, Masaki Igarashi, Rie Matsumori, Kiyoaki Ishii, Yoshimi Nakagawa, Hitoshi Iwasaki, Kazuto Kobayashi, Shigeru Yatoh, Akimitsu Takahashi, Hirohito Sone, Hiroaki Suzuki, Naoya Yahagi, Nobuhiro Yamada, Hitoshi Shimano.   

Abstract

OBJECTIVE: Elovl6, a long-chain fatty acid elongase, is a rate-limiting enzyme that elongates saturated and monounsaturated fatty acids and has been shown to be related to obesity-induced insulin resistance via modification of fatty acid composition. In this study, we investigated the roles of Elovl6 in foam cell formation in macrophages and atherosclerosis in mice. METHODS AND
RESULTS: To investigate the roles of Elovl6 in macrophages in the progression of atherosclerosis, we transplanted bone marrow cells of wild-type or Elovl6(-/-) mice into irradiated LDL-R(-/-) mice that were fed a western diet. Aortic atherosclerotic lesion areas and infiltration of macrophages were significantly smaller in Elovl6(-/-) bone marrow cells-transplanted LDL-R(-/-) mice than in wild-type. Accumulation of esterified cholesterol on exposure to acetylated-LDL was less severe in peritoneal macrophages from Elovl6(-/-) mice than those from wild-type. Cholesterol efflux and expression of cholesterol efflux transporters were increased in Elovl6(-/-) macrophages, although no difference in uptake of acetylated-LDL was found between the two groups. On analysis of fatty acid composition of the esterified cholesterol fraction in macrophages, n-6 polyunsaturated fatty acids were decreased by absence of Elovl6.
CONCLUSIONS: These findings suggest that Elovl6 in macrophages may contribute to foam cell formation and progression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21817094     DOI: 10.1161/ATVBAHA.110.221663

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Sonja M Kessler; Yvette Simon; Katja Gemperlein; Kathrin Gianmoena; Cristina Cadenas; Vincent Zimmer; Juliane Pokorny; Ahmad Barghash; Volkhard Helms; Nico van Rooijen; Rainer M Bohle; Frank Lammert; Jan G Hengstler; Rolf Mueller; Johannes Haybaeck; Alexandra K Kiemer
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

2.  Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.

Authors:  Eyra Marien; Michael Meister; Thomas Muley; Teresa Gomez Del Pulgar; Rita Derua; Jeffrey M Spraggins; Raf Van de Plas; Frank Vanderhoydonc; Jelle Machiels; Maria Mercedes Binda; Jonas Dehairs; Jami Willette-Brown; Yinling Hu; Hendrik Dienemann; Michael Thomas; Philipp A Schnabel; Richard M Caprioli; Juan Carlos Lacal; Etienne Waelkens; Johannes V Swinnen
Journal:  Oncotarget       Date:  2016-03-15

3.  Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) Signaling.

Authors:  Hiroaki Sunaga; Hiroki Matsui; Saki Anjo; Mas Risky A A Syamsunarno; Norimichi Koitabashi; Tatsuya Iso; Takashi Matsuzaka; Hitoshi Shimano; Tomoyuki Yokoyama; Masahiko Kurabayashi
Journal:  J Am Heart Assoc       Date:  2016-11-23       Impact factor: 5.501

4.  Elovl6 regulates mechanical damage-induced keratinocyte death and skin inflammation.

Authors:  Yoshiyuki Nakamura; Takashi Matsuzaka; Satoko Tahara-Hanaoka; Kazuko Shibuya; Hitoshi Shimano; Chigusa Nakahashi-Oda; Akira Shibuya
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

5.  Molecular Characterization, Nutritional and Insulin Regulation of Elovl6 in Rainbow Trout (Oncorhynchus mykiss).

Authors:  Yongnan Li; Yuning Pang; Zengqi Zhao; Xiaojun Xiang; Kangsen Mai; Qinghui Ai
Journal:  Biomolecules       Date:  2020-02-10

6.  Crucial Role of Elovl6 in Chondrocyte Growth and Differentiation during Growth Plate Development in Mice.

Authors:  Manami Kikuchi; Masako Shimada; Takashi Matsuzaka; Kiyoaki Ishii; Yoshimi Nakagawa; Misa Takayanagi; Nobuhiro Yamada; Hitoshi Shimano
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

7.  Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-/-) mouse model.

Authors:  Motoko Kuba; Takashi Matsuzaka; Rie Matsumori; Ryo Saito; Naoko Kaga; Hikari Taka; Kei Ikehata; Naduki Okada; Takuya Kikuchi; Hiroshi Ohno; Song-Iee Han; Yoshinori Takeuchi; Kazuto Kobayashi; Hitoshi Iwasaki; Shigeru Yatoh; Hiroaki Suzuki; Hirohito Sone; Naoya Yahagi; Yoji Arakawa; Tsutomu Fujimura; Yoshimi Nakagawa; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.